Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07270302 · ClinicalTrials.gov registry record · Phase 1
Nebulized Nasal Steroids
A Phase 1 study, sponsored by Washington University School of Medicine.
- Not yet
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT07270302 is a Phase 1 study that has not yet begun recruiting, run by Washington University School of Medicine. The registered enrollment target is 50 participants.
The verdict
NCT07270302, a Phase 1 study, has not yet begun recruiting, sponsored by Washington University School of Medicine.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of the proposed project is to assess the efficacy, safety, and patient experience of budesonide administered via the NasoNeb system for medical management of CRS. The authors propose a randomized controlled trial of nebulized budesonide via the NasoNeb compared against budesonide lavage.
Interventions
- COMBINATION_PRODUCT nebulized budesonide via NasoNeb
- COMBINATION_PRODUCT budesonide lavage via NeilMed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-12 |
| Est. Completion | 2026-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07270302
The ClinicalTrials.gov registry entry for NCT07270302 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which nebulized budesonide via NasoNeb is the first listed.
NCT07270302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07270302 about?
NCT07270302 is a clinical study titled "Nebulized Nasal Steroids". The goal of the proposed project is to assess the efficacy, safety, and patient experience of budesonide administered via the NasoNeb system for medical management of CRS. The authors propose a randomized controlled trial of nebulized budesonide via the NasoNeb compared against budesonide lavage.
What is the current status of trial NCT07270302?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2025-12. Estimated completion is 2026-05.
What interventions are being tested in trial NCT07270302?
The interventions under investigation include: nebulized budesonide via NasoNeb (COMBINATION_PRODUCT), budesonide lavage via NeilMed (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT07270302?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.